pre-IPO PHARMA

COMPANY OVERVIEW

Transcenta is a clinical stage global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, development and manufacturing. Transcenta has established global footprint, with Headquarter and Discovery and Translational Research Center in Suzhou, Process and Product Development Center and Manufacturing Facility in Hangzhou, and Clinical Development Centers in Beijing, Shanghai and Guangzhou in China and in Princeton, US, and External Partnering Center in Boston, US. Transcenta is developing a panel of nine antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. Upon the latest financing, the company has raised over $342 million from globally prominent investors.


LOCATION

  • Suzhou, None, China
  • Shanghai, None, China
  • Hangzhou, None, China
  • Beijing, None, China
  • Waltham, MA, USA
  • Princeton, NJ, USA

  • THERAPEUTIC AREAS

  • Autoimmune Disease
  • Oncology

  • WEBSITE

    http://www.transcenta.com/


    CAREER WEBSITE

    http://www.transcenta.com/careers/Experienced_Professionals


    SOCIAL MEDIA


    INVESTORS

    arch-venture-partners china-capital china-equity-group china-merchants-capital china-structural-reform-fund country-garden-venture-capital crcp epiphron-capital fortune-capital hillhouse-capital kingstar-capital lilly-asia-ventures qatar-investment-authority, sequoia-capital-china taikang temasek teng-yue-partners


    PRESS RELEASES


    Nov 10, 2022

    Transcenta Presented Two Scientific Posters at SITC 2022 Annual Meeting


    Nov 9, 2022

    Transcenta to Hold 3 Exchange Sessions on Post-SITC Business Update Call and TST003 data release and pipeline development progress update


    Oct 24, 2022

    Transcenta To Present First-In-Class TST003 Antibody Program at the 10th TEMTIA Meeting


    Oct 24, 2022

    Transcenta to Participate in Four Upcoming Conferences


    Oct 13, 2022

    Transcenta to Present Two Scientific Posters at SITC 2022 Annual Meeting


    For More Press Releases


    Google Analytics Alternative